RE:RE:RE:BlockedHopeful, Management teams never seperate shareholders into small fish/big fish. They have a responsibility to act in the best interest of all shareholders. MedX is accountable to all shareholders. The big boys you are alluding to are in your best interest. If institutional money is investing in MedX it means MedX has passed tougher scruitiny than if it were just retail shareholders owning the stock. If you remember back a few years ago MedX traded 25-30,000 shares on a good day now the volume is well over 300-600,000 share at times so that is increased liquidity and better price stability. MedX now has independant research (not paid for) from Beacon Capital which is another achievement. MedX is able to fund itself so the company will not go under or be forced to deeply dillutional round that would wipe out your investment.
The key is MedX has been able to attract world-class dermatologists and sales people who have already been impactive in MedX's revenue generation and product development. I know sales have taken time and yes we are all frustrated so if you believe management knows how to operate a company and has the proper vision you stay long.